期刊文献+

异型流感病毒感染小鼠T细胞亚群变化研究 被引量:1

Changes in T lymphocyte subsets of mice infected with the heterosubtypic influenza virus
原文传递
导出
摘要 目的制备能够抵御不同类型流感病毒感染疫苗,揭示机体对异型流感病毒感染交叉免疫保护作用的主要机制。方法小鼠流感病毒疫苗免疫后分别感染同型、异型流感病毒,另设使用免疫增强剂IL-2后感染异型流感病毒组,观察小鼠的一般状况和肺指数,并用流式细胞术检测小鼠肺和脾中的CD4+、CD8+T细胞水平。结果异型免疫组和异型免疫加强组流感病毒感染后小鼠肺和脾中CD4+、CD8+T细胞百分率显著高于感染前及同型免疫组和对照组(P<0.05)。病毒感染后7d,同型免疫组和异型免疫加强组小鼠存活率均为100%,异形免疫组为67%。结论小鼠感染异型流感病毒后CD4+、CD8+T细胞水平显著增高,此细胞可能在流感病毒异型间交叉保护免疫应答反应中起重要作用,其机制有待进一步研究。 Objective To prepare vaccines against the different subtypes of influenza virus and reveal the main mecha- nism of cross-protective immunity from heterosubtypic influenza virus infection. Methods Mice immunized with influ- enza virus vaccine were infected with the same type and heterosubtypic influenza virus, and a group of mice were injected with IL-2 as an immunostimulant after heterosubtypic influenza virus infection. The general condition and lung index of mice were observed, lung homogenates were collected, and the CD4+ , CD8+T cell levels were detected in the lungs and spleen using flow cytometry. Results The percentage of CD4+ , CD8+ T cells in the lungs and spleen was significantly higher after heterosubtypic influenza virus infection (P-~0.05) compared to mice infected with the same type of influenza virus or mock-infected. Seven days after influenza virus infection, the group infected with the same type and the group u sing an immunostimulant both had a survival rate of 100~ ; the group infected with only the heterosubtypic influenza virus had a survival rate of 67~. Conclusion The percentage of CD4+ , CD8+T ceils significantly increased after heterosub typic influenza virus infeetion, and these cells may play an important role in immunity against heterotypic influenza virus infection. The mechanism of this increase in lymphocytes must be studied further.
出处 《中国病原生物学杂志》 CSCD 北大核心 2013年第1期23-25,45,共4页 Journal of Pathogen Biology
基金 教育部高等学校博士学科点专项科研基金项目(No.20102104110018)
关键词 流感病毒 异型 IL-2 CD4+、CD8+T细胞 Influenza virus heterosubtypie IL-2 CD4+ and CD8+T lymphocyte
  • 相关文献

参考文献10

  • 1Chen W, Calvo PA, Malide D, et al. A novel influenza A virus mitochondrial protein that induces that induce cell death [J]. Nat Med, 2001, 7(12):1306-12.
  • 2Heiny AT, Miotto O, Srinivasan KN, et al. Evolutionarily con- served protein sequences of influenza a viruses, avian and human, as vaccine targets[J]. PLoSone, 2007, 2(11): e1190.
  • 3Seo SH, Peiris M, Webster RG. Protective cross-reactive cellular immunity to lethal A/Goose/Guangdong/1/96-1ike HSN1 nfluenza virus is correlated with the proportion of pulmonaryCD8+ T cells expressing gamma interferon[J]. JVI, 2002, 76 (10) : 4886-90.
  • 4Droebner K, Haasbach E, Fuchs C, et al. Antibodies and CD4+- cells mediate cross-protection against H5N1 influenza virus infec tion in mice after vaccination with a low pathogenic HSN2 strain [J]. Vaccine, 2008, 26(52): 6965-74.
  • 5Ichinohe T, Ainai A, Nakamura T, et aI. Induction of cross-pro- tective immunity against influenza A virus HSN1 by an intranasal vaccine with extracts of mushroom mycelia[J]. Med Virol, 2010, 82(1): 128-37.
  • 6Boon AC, de Mutsert G, van Baarle D, et al. Recognition of ho mo- and heterosubtypic variants of influenza A viruses by human CDS+Tlymphocytes[J]. J Immunol, 2004, 172(4): 2453-60.
  • 7Nguyen HH, Ginkel FW, Vu HL, et al. Heterosubtypic immu- nity to influenza A virus infection requires B ceils but not CD8+ cytotoxic T lymphocytes[J]. J Infect Dis, 2001, 183(3) : 368- 76.
  • 8郭志华,牛术孟,金红.异型流感病毒感染小鼠肺细胞因子水平变化[J].微生物学杂志,2011,31(4):74-79. 被引量:5
  • 9姚春艳,姜丽娜,郭术俊,马华.腹腔注射IL-2对小鼠单核吞噬细胞吞噬功能的影响[J].山西医科大学学报,2007,38(3):202-203. 被引量:4
  • 10Slepushkin VA, Katz JM, Black RA, et al. Protection of mice against influenza A virus challenge by vaccination with baculovius- expressed Mz protein[J]. Vaccine, 1995, 13(15):1399-402.

二级参考文献17

  • 1黄清松,邹燕,林元藻,付柏绿.鸡卵黄免疫球蛋白(IgY)对小鼠单核吞噬细胞吞噬功能的影响[J].广东药学院学报,2005,21(5):585-586. 被引量:6
  • 2姚春艳,姜丽娜,郭术俊,马华.腹腔注射IL-2对小鼠单核吞噬细胞吞噬功能的影响[J].山西医科大学学报,2007,38(3):202-203. 被引量:4
  • 3Hsieh YC, Wu TZ, Liu DP, et al. Influenza pandemics: past, present and future [J]. J Formos Med Assoc,2006,105 ( 1 ) : 1-6.
  • 4Flahauh A,Vergu E, Boene PY. Potential for a global dynamic of influenza A (H1N1) [J]. BMC Infect Dis,2009,9 ( 1 ) :129.
  • 5Sorianov,Gonzalez-Lahoz J. The challenge of the new H1N1 influenza A [J]. Med Clin (Barc) ,2009,133 ( 18 ) :708-709.
  • 6De Jong MD, Tran TR, Tmong HK, et al. Oseltamivir resistance during treatment of influenza A (H1N1) infection [J]. N EllgI J Med, 2005,353 (25) :2667-2672.
  • 7Tamura SI, Tanimoto T, Kurata T. Mechanisms of broad crossprotection provided by influenza virus infection and their application to vaccines[ J]. Infect Dis,2005,58 : 195-207.
  • 8Boon AC, de Mutsert G, van Baarle D, et al. Recognition of hemo-and heterosubtypie variants of influenza A viruses by human CD8^+ T lymphoeytes[ J]. Immunol,2004,172 (4) :2453- 2460.
  • 9Nguyen HH, Ginkel FW, Vu HL, et al. Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8^+ cytotoxic T lymphocytes [J]. J Infect Dis, 2001,183 ( 3 ) :368- 376.
  • 10Droebner K, Haasbach E, Fuchs C, et al. Antibodies and CD4^+-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic HSN2 strain[J]. Vaccine ,2008,26 (52) :6965-6974.

共引文献7

同被引文献13

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部